Voronoi, Inc. Logo

Voronoi, Inc.

Develops selective kinase inhibitors and targeted protein degraders for precision oncology.

310210 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도과학로 32 에스동 18층, 연수구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Voronoi, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of novel therapeutics, with a primary focus on precision medicine for oncology. The company's expertise lies in creating innovative kinase inhibitors and targeted protein degraders. Voronoi leverages its proprietary drug discovery platform, VORONOMICS™, to rapidly identify and optimize drug candidates. This platform is designed to develop therapies with high selectivity and the ability to penetrate the brain barrier. Its pipeline includes targeted treatments for various cancers, such as non-small cell lung cancer (NSCLC) and HER2-positive solid tumors, aiming to accelerate the delivery of new therapies from design to the clinic.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Voronoi, Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-18 00:00
M&A Activity
투자판단관련주요경영사항 (VRN04 프로그램 연구에 대한 옵션 행사 및 자산 구매 계약 체결)
Korean 10.7 KB
2025-09-08 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 125.2 KB
2025-09-05 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 121.8 KB

Automate Your Workflow. Get a real-time feed of all Voronoi, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Voronoi, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NRGene Technologies Ltd. Logo
AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.
Israel NRGN
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway NYKD
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland OCS
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea 244460
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea 382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea 476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan 4564
Onxeo Logo
Developing precision-guided therapeutics using small antibodies for complex diseases.
France ALONX
Openedges Technology, Inc. Logo
Semiconductor IP provider of memory subsystem & AI platform IP for AI, HPC, and IoT SoCs.
South Korea 394280
Openjobmetis Logo
Employment agency providing staffing, recruitment, and HR services to companies and job seekers.
Italy OJM

Talk to a Data Expert

Have a question? We'll get back to you promptly.